Involvement of Adenosine A1 and A2A Receptors in the Motor Effects of Caffeine after its Acute and Chronic Administration
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The involvement of adenosine A(1) and A(2A) receptors in the motor effects of caffeine is still a matter of debate. In the present study, counteraction of the motor-depressant effects of the selective A(1) receptor agonist CPA and the A(2A) receptor agonist CGS 21680 by caffeine, the selective A(1) receptor antagonist CPT, and the A(2A) receptor antagonist MSX-3 was compared. CPT and MSX-3 produced motor activation at the same doses that selectively counteracted motor depression induced by CPA and CGS 21680, respectively. Caffeine also counteracted motor depression induced by CPA and CGS 21680 at doses that produced motor activation. However, caffeine was less effective than CPT at counteracting CPA and even less effective than MSX-3 at counteracting CGS 21680. On the other hand, when administered alone in habituated animals, caffeine produced stronger motor activation than CPT or MSX-3. An additive effect on motor activation was obtained when CPT and MSX-3 were coadministered. Altogether, these results suggest that the motor-activating effects of acutely administered caffeine in rats involve the central blockade of both A(1) and A(2A) receptors. Chronic exposure to caffeine in the drinking water (1.0 mg/ml) resulted in tolerance to the motor effects of an acute administration of caffeine, lack of tolerance to amphetamine, apparent tolerance to MSX-3 (shift to the left of its 'bell-shaped' dose-response curve), and true cross-tolerance to CPT. The present results suggest that…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, functional interactions between A2A receptors and dopaminergic signaling pathways suggest that caffeine’s central stimulant effects likely arise from the broader disinhibition of a multi-neurotransmitter network, driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone [37,38].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [38]
Citations
Cites
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Pontieri, F. E., Tanda, G., & Di Chiara, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12304 · Cited by 868
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxe, K., B. Fredholm, B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 824
Self-citationAdenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694
(1962) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb27008.x · Cited by 586
Ferre, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxe, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 552
Self-citationHillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
Self-citationDopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 445
Self-citationRobinson, T. E., Gorny, G., Mitton, E., & Kolb, B. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3<257::aid-syn1007>3.0.co;2-1 · Cited by 402
Adenosine-dopamine interactions in the brain
Ferré, S., Fuxe, K., von Euler, G., Johansson, B., & Fredholm, B. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90291-9 · Cited by 364
Self-citationCaffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338
Yacoubi, M. E., Ledent, C., Ménard, J., Parmentier, M., Costentin, J., & Vaugeois, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703170 · Cited by 307
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., von Lubitz, D. K. J. E., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 263
Adenosine-dopamine interactions in the ventral striatum
Ferré, S. (1997) · Psychopharmacology · doi:10.1007/s002130050380 · Cited by 248
Self-citationCaffeine — an atypical drug of dependence
Daly, J. W., & Fredholm, B. B. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00077-5 · Cited by 240
Acquas, E. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00290-7 · Cited by 186
Cunha, R. A., Constantino, M. D., Sebasti�o, A. M., Johansson, B., & Fredholm, B. B. (1996) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00168627 · Cited by 184
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine
Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y., Fienberg, A. A., Bibb, J. A., Fredholm, B. B., Nairn, A. C., Greengard, P., & Fisone, G. (2002) · Nature · doi:10.1038/nature00817 · Cited by 180
Svenningsson, P., Nomikos, G. G., & Fredholm, B. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04011.1999 · Cited by 177
8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo
Jacobson, K. A., Nikodijević, O., Padgett, W. L., Gallo-Rodriguez, C., Maillard, M., & Daly, J. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81466-d · Cited by 173
Svenningsson, P., Nomikos, G. G., Ongini, E., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00046-8 · Cited by 170
Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic
Rimondini, R., Ferré, S., Ogren, S. O., & Fuxé, K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00033-x · Cited by 162
Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum
Okada, M., Mizuno, K., & Kaneko, S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12780-4 · Cited by 157
Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease
Ferré, S., Popoli, P., Giménez‐Llort, L., Rimondini, R., Müller, C. E., Strömberg, I., Ögren, S. O., & Fuxé, K. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00063-8 · Cited by 130
Self-citationAdenosine A2a receptors in the nucleus accumbens mediate locomotor depression
Barraco, R. A., Martens, K. A., Parizon, M., & Normile, H. J. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90233-2 · Cited by 122
Sauer, R., Maurinš, J. A., Reith, U., Fülle, F., Klotz, K., & Müller, C. E. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9911480 · Cited by 121
Self-citationPinna, A., Fenu, S., & Morelli, M. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3<233::aid-syn1004>3.0.co;2-k · Cited by 110
Nikodijević, O., Sarges, R., Daly, J. W., & Jacobson, K. A. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20519-5 · Cited by 108
Tolerance to behavioral effects of caffeine in rats
Holtzman, S. G., & Finn, I. B. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90179-7 · Cited by 95
Rimondini, R., Ferré, S., Giménez‐Llort, L., Ögren, S. O., & Fuxé, K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00107-1 · Cited by 80
Self-citationRamkumar, V, Bumgarner, J. R., Jacobson, K. A., & Stiles, G. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113577 · Cited by 72
Cohen, B. E., Lee, G., Jacobson, K. A., Kim, Y.-C., Huang, Z., Sorscher, E. J., & Pollard, H. B. (1997) · Biochemistry · doi:10.1021/bi970150v · Cited by 69
Flagmeyer, I., Haas, H. L., & Stevens, D. R. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01060-3 · Cited by 66
Chronic Effects of Xanthines on Levels of Central Receptors in Mice
Shi, D., & Daly, J. W. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006901005925 · Cited by 65
Ga̧sior, M., Jaszyna, M., Peters, J., & Goldberg, S. R. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39011-1 · Cited by 65
Self-citationWood, P. L., Kim, H. S., Boyar, W. C., & Hutchison, A. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90062-2 · Cited by 63
Behavioral and physiological effects of xanthines in nonhuman primates
Howell, L. L., Coffin, V. L., & Spealman, R. D. (1997) · Psychopharmacology · doi:10.1007/s002130050155 · Cited by 63
Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding
Baumgold, J., Nikodijević, O., & Jacobson, K. A. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90257-j · Cited by 63
Popoli, P., Reggio, R., Pèzzola, A., Fuxé, K., & Ferré, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00533-3 · Cited by 62
Self-citationMarston, H. M., Finlayson, K., Maemoto, T., Olverman, H. J., Akahane, A., Sharkey, J., & Butcher, S. P. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37508-1 · Cited by 62
Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity
Finn, I. B., & Holtzman, S. G. (1987) · Psychopharmacology · doi:10.1007/bf00207230 · Cited by 61
Caffeine potentiates the discriminative-stimulus effects of nicotine in rats
Ga̧sior, M., Jaszyna, M., Munzar, P., Witkin, J. M., & Goldberg, S. R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1113-3 · Cited by 60
Self-citationMaemoto, T., Finlayson, K., Olverman, H. J., Akahane, A., Horton, R. W., & Butcher, S. P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701465 · Cited by 57
Characterization of the locomotor depression produced by an A2‐selective adenosine agonist
Nikodijević, O., Daly, J. W., & Jacobson, K. A. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80638-y · Cited by 52
[3H]ZM241385—an antagonist radioligand for adenosine A2A receptors in rat brain
Alexander, S. P. H., & Millns, P. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00899-2 · Cited by 52
Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist
Halldner, L., Lozza, G., Lindström, K., & Fredholm, B. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00682-8 · Cited by 52
Popoli, P., Reggio, R., & Pèzzola, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00144-x · Cited by 49
Self-citationKaplan, G. B., Greenblatt, D. J., Kent, M. A., Cotreau, M. M., Arcelin, G., & Shader, R. I. (1992) · PubMed · Cited by 46
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Ongini, E., Costentin, J., & Vaugeois, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01771.x · Cited by 45
Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
Gołembiowska, K., & Żylewska, A. (1997) · PubMed · Cited by 38
Dose-dependent surmountability of locomotor activity in caffeine tolerance
Lau, C. E., & Falk, J. L. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00066-6 · Cited by 32
Jaszyna, M., Ga̧sior, M., Shoaib, M. C., Yaşar, S., & Goldberg, S. R. (1998) · Psychopharmacology · doi:10.1007/s002130050766 · Cited by 32
Self-citationTolerance to oral and IP caffeine: Locomotor activity and pharmacokinetics
Lau, C. E., & Falk, J. L. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90535-5 · Cited by 32
Holtzman, S. G. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90329-a · Cited by 30
Appel, S., Mathôt, R. A. A., Langemeijer, M. W. E., IJzerman, A. P., & Danhof, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15033.x · Cited by 22
Mathôt, R. A. A., Cleton, A., Soudijn, W., IJzerman, A. P., & Danhof, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13270.x · Cited by 22
Katz, J. L., & Goldberg, S. R. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39050-6 · Cited by 19
Self-citationOral and IP caffeine pharmacokinetics under a chronic food-limitation condition
Lau, C. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00306-4 · Cited by 17
Cited by
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 590
Self-citationAn Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440
Self-citationDall'Igna, O. P., Fett, P., Gomes, M. W., Souza, D. O., Cunha, R. A., & Lara, D. R. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372
Carriba, P., Ortiz, O., Patkar, K., Justinova, Z., Stroik, J., Themann, A., Müller, C., Woods, A. S., Hope, B. T., Ciruela, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301375 · Cited by 260
Self-citationMechanisms of the psychostimulant effects of caffeine: implications for substance use disorders
Ferré, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4212-2 · Cited by 208
Self-citation
Metadata
- Authors
- Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., Goldberg, S. R., Popoli, P., & Ferré, S.
- Affiliations
- National Institutes of Health (US)
- Karolinska Institutet (SE)
- Istituto Superiore di Sanità (IT)
- University of Bonn (DE)
- Corresponding author
- Ferré, Sergi
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2003-01-20
- Volume
- 28
- Issue
- 7
- Pages
- 1281-1291
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2056124241
- Cited by
- 189
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 8 · 2018: 14 · 2017: 7 · 2016: 6 · 2015: 10 · 2014: 12 · 2013: 7 · 2012: 8
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, adenosine A1 receptor, adenosine A2A receptor, motor activation, caffeine tolerance, cross-tolerance, CPT, MSX-3, CPA, CGS 21680, receptor antagonists
- MeSH terms
- Adenosine, Amphetamine, Central Nervous System Stimulants, Animals, Behavior, Animal, Caffeine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Male, Motor Activity, Phenethylamines, Radioligand Assay, Theophylline, Time Factors, Triazines, Triazoles, Tritium, Xanthines, Rats, Sprague-Dawley, Receptors, Purinergic P1, Receptor, Adenosine A2A, Rats, Purinergic P1 Receptor Agonists, Purinergic P1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.